AU Patent

AU2001285349A1 — Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2

Assigned to University of Arkansas at Little Rock · Expires 2002-03-13 · 24y expired

What this patent protects

Patent listed against Mektovi.

Drugs covered by this patent

Patent Metadata

Patent number
AU2001285349A1
Jurisdiction
AU
Classification
—
Expires
2002-03-13
Drug substance claim
No
Drug product claim
No
Assignee
University of Arkansas at Little Rock
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.